Lauren Unsworth

Are you interested in joining Myriad Genetics?🧬 Watch this video to see a step-by-step tutorial on how to view all of our open requisitions and how to apply at Myriad.com. #openpositions #genetictesting #genetics #recruitment #precisionmedicine #applynow

58

2 Comments

Dear Hiring Managers! Time for a #funfact (Brought to you by Shrishti Singh, Ph.D.) Did you know hiring PhDs in biotech doesn't just mean bringing on someone with niche skill sets who can perform experiments? PhDs have a ton of core and transferable skills they bring to every job. Here is a nice illustration summarizing some of those key skills! #PhD #Biotech #Hiring #Talent #TransferableSkills #CoreSkills

12

3 Comments

Curious about the labs and facilities where Wistar Science happens? Take a virtual tour of The Wistar Institute’s Flow Cytometry Facility. Click, drag, and zoom to explore the space and learn about cell sorting, cell analysis, and the array of tools available for scientists to use in their research. https://lnkd.in/e59sRde4

1

Recruiter tip: For biotech job applications, do not put graphics in your resume. We sometimes see a resume with graphs or colorful elements to describe the candidate's experience. While the candidate understands what they meant, the recruiter has no clue! What exactly is 4 out of 5 stars for cell culture experience? It leads the recruiter or manager to question a resume more than to consider it. Keep your resume format simple and clean. Boring and black-and-white is best!

20

#AAI24 Poster Alert! Targeted Antibody Conjugates Using Sortase & AbFlex® Technology, by Dr. Mary Anne Jelinek. This NOVEL technology delivers an array of conjugates using sortase & #clickchemistry - Download the poster ➡ https://bit.ly/3VGswKs

28

2 Comments

#ScientificWednesday: Exciting News in Drug Discovery! 🚀 Researchers at the Frederick National Laboratory for Cancer Research and the National Cancer Institute (NCI) have developed a cutting-edge CRISPR screening platform, revolutionizing how we identify protein-molecule interactions crucial for drug development. 🧬🔬 ❗️ Why It Is Important: ⭐️ Advanced CRISPRa Technology It activates genes to increase receptor presence on cell surfaces, simplifying interaction detection. ⭐️ Enhanced Sensitivity Nano-sized magnetic beads improve detection of low-affinity interactions, essential for effective and safe drugs. ⭐️ Major Discovery The research identified a new low-affinity protein-receptor pair, paving the way for innovative treatments. ⭐️ Public gRNA Libraries New libraries are now available in the Addgene database to support global research efforts. This platform could drive the development of next-generation drugs, making treatments more efficient and accessible. Congratulations to the brilliant minds pushing the boundaries of science: Liping Yang, Timothy Sheets, M.S., Ph.D., Yang Feng, Pradip Bajgain, Kuo-Sheng Hsu, Daeho So, Steven Seaman, Jaewon Lee, Ling Lin, Christine N. Evans, Mary R. Guest, Raj Chari, and Brad St. Croix ! 👏💡 🔎 Read more: https://lnkd.in/gQzxcSxs #DrugDiscovery #CRISPR #Biotechnology #CancerResearch #Innovation Image source: Daily Mail UK https://lnkd.in/gqkfJexc

7

Shan D., our Vice President of Strategy and Innovation, is passionate about leveraging collaborative partnerships to drive 3D biology adoption industrywide and advocating for diversity earlier in drug development. Check out his latest published perspectives on these topics and more: https://ow.ly/kjrS50SkVKO. 📰 Organoids Stand Out as Stand Ins in Drug Development: https://lnkd.in/e4tg8TSs 📰 New Collaboration Finds a Match Between Liver-Derived Organoids and Automated Screening Technologies: https://lnkd.in/gnG2zf6e 📰 The Benefits of AI and Automation in the Cell Culture Process: https://lnkd.in/gKbEDCU2 📰 The Importance of Introducing Diversity Earlier in Drug Development: https://lnkd.in/g4vDZc9A #3dbiology #3dcellculture #organoids #drugdiscovery #drugscreening #drugdevelopment #diseasemodeling #labautomation #ai #machinelearning #deeplearning #highcontentimaging #highcontentscreening #scienceandtechnology #pharma #geneeditting #cellculture #pdo #imageanalysis

28

1 Comment

📢 #Pharmacogenomics (#PGx) plays a crucial role in our mission at the Institute for Precision Medicine. Under the guidance of Philip Empey, PharmD, PhD, Associate Director at IPM and Associate Professor at the University of Pittsburgh School of Pharmacy, UPMC’s system-wide clinical implementation of PGx is facilitated by the PreCISE-Rx Program. This program enhances patient care by integrating clinical decision tools into electronic health records, allowing tailored treatment based on #genetic findings. To explore how pharmacogenomics can lead to improved patient outcomes, read our updated IPM brochure [Page 12-13]: https://lnkd.in/ehqkGf5x

4

Immunohistochemistry exploits antibody-antigen interactions to identify specific proteins and other antigens in cells & tissue. Learn more about LVEMs role, sample preparation, and indirect labeling for immunohistochemistry. https://bit.ly/4bekmNr

8

Traditional methods reliant on individual #genereplacement strategies have shown their limitations, targeting only a specific gene for a specific disease. This specialized therapeutic approach can be both slow and costly to develop. Researchers are now investigating ways to use a single modifier gene to treat an array of diseases. This gene-agnostic approach using modifier #genetherapy could address genetically diverse diseases, writes Huma Qamar MD, MPH of Ocugen in this new Cell & Gene article. https://lnkd.in/e82DTakR

9

1 Comment

Looking to detect LC3, p62, ATG5 or other autophagy-related targets? View Bioss' collection of autophagy antibodies here: https://hubs.ly/Q02nb5yh0

3

In an recent interview with SelectScience®, study author Karina Eterovic, MSc, PhD, NYS CoQ, R&D Director of Oncology Diagnostics at Eurofins Viracor BioPharma Services, discussed the complex interplay between clonal hematopoiesis (CH) and cancer genomics, in the context of precision of oncology therapy development, cancer diagnosis and treatment. She shared the results of a recent study that emphasize the potential need to integrate routine germline sequencing into clinical practice to prevent the misclassification of CH aberrations. Findings identified somatic CH mutations in a substantial subset of patients with advanced solid tumors. This has implications for accurate treatment decisions in cancer patients, as distinguishing between tumor-derived mutations and CH mutations is crucial. Read more here: https://lnkd.in/ezM6KXWx #onocologyresearch #cancer #genomics #eurofins #testingforlife #biopharma Eurofins Bioanalytical Services Eurofins Central Laboratory Eurofins Clinical Trial Supplies

44

The field of #biologics is growing and transforming thanks to various advancements. Check out what Anupreet Kaur from National Institute of Standards and Technology (NIST) and Peter Timmerman and Hans de Backer from Biosynth had to say on the subject in May's Cover Story: https://ow.ly/BmIn50RA4WV

7

Say "HEK no!" to risky residual DNA from HEK293 host cells in gene therapy. Safeguard with Vericheck ddPCR HEK293 Residual DNA Size Kit: https://lnkd.in/gKYNrpJh Residual DNA from immortalized cell lines, such as HEK293, can harbor potentially harmful genetic or retroviral sequences. To mitigate these risks, the FDA recommends that manufacturers degrade any residual host cell DNA to <200 base pairs. The Vericheck ddPCR HEK293 Sizing Kit leverages the power and efficiency of ddPCR technology to provide a specific, sensitive solution for measuring HEK293 size without the need for reference curves. #ddPCR #GeneTherapy #HEK293

97

New in JBC press: "Scientists' results suggest a new mode of regulatory control of mitochondrial energetics through modulation of FOXK2 cellular abundance." Learn more: https://lnkd.in/eiE8t8es

3